Precision Cancer Care and Immunotherapy
Date(s) - 08/30/2022
1:00 pm - 2:00 pm
Register for this webinar to learn how precision cancer care and immunotherapy, one of the most promising new cancer treatments, can turn the power of the immune system against cancer cells.
Join us to learn the what, why and how of precision medicine and immunotherapy. Immunotherapy can treat many different types of cancer. Today it can be used alone or in combination with chemotherapy and/or other cancer treatments.
Session participants will understand:
- What is precision cancer care and immunotherapy
- How immunotherapy treatment works
- Types of cancer that respond well to immunotherapy
- What one can do to get ready for this type of treatment
- What are the short-term and long-term side effects of treatment
- New advanced treatment options for precision medicine and immunotherapy
About our speaker:
Jue Wang, MD, Medical Oncologist with Dignity Health – Cancer Institute at St. Joseph’s Hospital and Medical Center.
Jue Wang, MD, is the Section Leader for Genitourinary Oncology clinic. and Chair of the Oncology Scientific Review Committee at Dignity Health Cancer Institute, St. Joseph’s Hospital and Medical Center. He is also a professor of medicine at Creighton University School of Medicine and at the University of Arizona College of Medicine – Phoenix.
Dr Wang is an internationally known expert for his research on diagnosis, treatment and outcome of rare lethal cancers, such as sarcomatoid prostate, bladder, and renal-pelvis carcinoma. His research focuses on improving effectiveness of cancer treatment by incorporating precision medicine strategies into clinical trial design and clinical care. He has conducted many clinical trials focused mainly on genitourinary oncology and precision oncology.
Dr. Wang serves on the editorial boards of numerous academic journals and has more than 100 peer-reviewed publications and book chapters. Dr Wang has strong interest in applying artificial intelligence (AI) and big data in cancer care and precision oncology, he is the co-inventor of Genomic Patient Intelligence (GPI), and has been recognized as Castle Connolly Top Doctor in the specialty of Medical Oncology for the last nine years.
For more information, contact Irene Cassidy at: